Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disordersMaria Gabriella Brasca, Daniele Donati, Nilla Avanzi et al.|Bioorganic & Medicinal Chemistry|2015Cited by 20
Abstract A179: NMS-P113, a novel orally available JAK2 selective inhibitorPaola Gnocchi, Arturo Galvani, Maria Gabriella Brasca et al.|Molecular Cancer Therapeutics|2015Cited by 0